15/09/2015 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Hot topics CQC annual report: safer management of controlled drugs The UK Care Quality Commission (CQC) has published their 2014 annual report on the safer management of controlled drugs and made […]
Category: Updates from www.palliativedrugs.com
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Safety Updates MHRA further measures to minimise risk of osteonecrosis of the jaw with denosumab and IV bisphosphonates Following a review by MHRA and other EU regulators, denosumab 120mg is now […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Hot topics Cochrane review: Palliative interventions for controlling vaginal bleeding in advanced cervical cancer This new Cochrane review (CD011000) has been published in full on-line. Drug updates Co-danthramer and […]
News and updates from www.palliativedrugs.com
Safety updates Potential risk of error in selecting incorrect oxycodone strength The National Pharmacy Association (NPA) has warned that incidents have occurred involving the selection of the wrong strength of oxycodone oral solution by prescribers on Egton Medical Information Systems (EMIS), used by GP surgeries. This appears to be due to the fact that the oxycodone 10mg/mL solution […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Court ruling requires NHS England to issue guidance for the prescribing and dispensing of pregabalin for neuropathic pain Generic pregabalin capsules are now available in all usual strengths (25mg, 50mg, 75mg, 100mg, 150mg, 225mg, 300mg and […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Patient Safety Alert for Fluid/Food Thickening Powder NHS England has issued a patient safety alert (NHS/PSA/W/2015/002) warning of the risk of death from asphyxiation by accidental ingestion of fluid/food dry thickening powder. For more information, click […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Patient Safety Alert for Potassium Permanganate NHS England has issued a patient safety alert (NHS/PSA/W/2014/18) warning of the risk of death or serious harm from accidental ingestion of potassium permanganate products. Potassium permanganate products are for […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety Alerts Gabapentin and Pregabalin Potential for Misuse Public Health England and NHS England have published advice for prescribers on the risk of misuse of gabapentin and pregabalin. For more information, click here. Hot Topics Drugs […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Naloxone – Patient Safety Alert NHS England has produced a Patient Safety Alert warning of the risk of distress and death from inappropriate doses of naloxone in patients on long-term opioid treatment (NHS/PSA/W/2014/016R). The alert […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Nitrofurantoin contra-indications updated The guidance for using nitrofurantoin in renal impairment has changed. Nitrofurantoin is now contra-indicated in patients with an estimated glomerular filtration rate (eGFR) of <45mL/min/1.73m2. However, a short course (3–7 days) may be […]